Identification of high-risk patients in multiple myeloma using a clonal gene signature

被引:0
|
作者
Li, Jian-Rong
Wang, Christiana
Cheng, Chao
机构
关键词
D O I
10.1158/1538-7445.AM2024-7663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7663
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Multiple Myeloma DREAM Challenge: A crowd-sourced challenge to improve identification of high-risk patients
    Mason, Michael
    Amatangelo, Michael
    Auclair, Daniel
    Bassett, Doug
    Dai, Hongyue
    Dervan, Andrew
    Flynt, Erin
    Goldschmidt, Hartmut
    Hose, Dirk
    Mavrommatis, Konstantinos
    Morgan, Gareth
    Munshi, Nikhil
    Ratushny, Alex
    Rozelle, Dan
    Samur, Mehmet
    Schmitz, Frank
    Shain, Ken
    Thakurta, Anjan
    Towfic, Fadi
    Trotter, Matthew
    Walker, Brian
    White, Brian S.
    Yu, Thomas
    Guinney, Justin
    CANCER RESEARCH, 2017, 77
  • [22] Definition and therapy of high-risk Multiple Myeloma
    Willenbacher, W.
    Willenbacher, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 242 - 242
  • [23] TREATMENT OF HIGH-RISK TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS
    Patriarca, F.
    HAEMATOLOGICA, 2021, 106 (10) : 209 - 211
  • [24] Evolutionary biology of high-risk multiple myeloma
    Charlotte Pawlyn
    Gareth J. Morgan
    Nature Reviews Cancer, 2017, 17 : 543 - 556
  • [25] Understanding high-risk smoldering multiple myeloma
    Kreiniz, Natalia
    Gertz, Morie A.
    LEUKEMIA & LYMPHOMA, 2023, 64 (08) : 1361 - 1372
  • [26] Unifying the Definition of High-Risk in Multiple Myeloma
    Siegel, Ariel
    Boyle, Eileen M.
    Blaney, Patrick
    Wang, Yubao
    Ghamlouch, Hussein
    Choi, Jinyoung
    Caro, Jessica
    Williams, Louis
    Razzo, Beatrice
    Arbini, Arnaldo A.
    Braunstein, Marc
    Kaminetzky, David
    Auclair, Daniel
    Pawlyn, Charlotte
    Cairns, David
    Jackson, Graham
    Walker, Brian
    Bruno, Benedetto
    Morgan, Gareth J.
    Davies, Faith E.
    BLOOD, 2021, 138
  • [27] Evolutionary biology of high-risk multiple myeloma
    Pawlyn, Charlotte
    Morgan, Gareth J.
    NATURE REVIEWS CANCER, 2017, 17 (09) : 543 - 556
  • [28] Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics
    Kumar, Shaji
    Fonseca, Rafael
    Ketterling, Rhett P.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dingli, David
    Knudson, Ryan A.
    Greenberg, Alexandra
    Russell, Stephen J.
    Zeldenrust, Steven R.
    Lust, John A.
    Kyle, Robert A.
    Bergsagel, Leif
    Rajkumar, S. Vincent
    BLOOD, 2012, 119 (09) : 2100 - 2105
  • [29] Current Review on High-Risk Multiple Myeloma
    Chan, Henry S. H.
    Chen, Christine I.
    Reece, Donna E.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (02) : 96 - 108
  • [30] Defining and treating high-risk multiple myeloma
    Usmani, S. Z.
    Rodriguez-Otero, P.
    Bhutani, M.
    Mateos, M-V
    Miguel, J. S.
    LEUKEMIA, 2015, 29 (11) : 2119 - 2125